SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-337594
Filing Date
2021-11-23
Accepted
2021-11-23 08:14:04
Documents
14
Period of Report
2021-11-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d261318d8k.htm   iXBRL 8-K 27916
2 EX-99.1 d261318dex991.htm EX-99.1 9692
6 GRAPHIC g261318g1123024802493.jpg GRAPHIC 2863
  Complete submission text file 0001193125-21-337594.txt   169797

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20211122.xsd EX-101.SCH 2895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20211122_lab.xml EX-101.LAB 18139
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20211122_pre.xml EX-101.PRE 11410
7 EXTRACTED XBRL INSTANCE DOCUMENT d261318d8k_htm.xml XML 3348
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 211434756
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences